US Broker Ratings

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 73.9% Potential Upside with a Revolutionary Medical Device

Investors seeking growth opportunities in the healthcare sector may want to closely examine TransMedics Group, Inc. (NASDAQ: TMDX). As a pioneering force in medical technology, TransMedics is at the forefront..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 52% Potential Upside in a Booming Biotech Market

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the biotechnology sector, with a market capitalization of $39.39 billion. Headquartered in Cambridge, Massachusetts, Alnylam is a trailblazer..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 22.93% Potential Upside

Baxter International Inc. (NYSE: BAX), a seasoned player in the healthcare sector, has long been a trusted provider of medical instruments and supplies. Headquartered in Deerfield, Illinois, the company operates..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 27.85% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a beacon of innovation in the biotechnology industry, specifically targeting RAS-addicted cancers with its precision oncology therapies. With a market capitalization of $30.15..

Repligen Corporation (RGEN): Investor Outlook Reveals 45.62% Potential Upside in Bioprocessing Innovator

Repligen Corporation (NASDAQ: RGEN) stands as a formidable player in the healthcare sector, specifically within the realm of medical instruments and supplies. With a market capitalization of $6.96 billion, this..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 7.81% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to turn their attention to Integer Holdings Corporation (NYSE: ITGR), a key player in the medical devices industry. With a current..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a Potential 11.49% Upside

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the global healthcare sector, specializing in medical instruments and supplies with a particular focus on eye health. Headquartered..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 22.72% Potential Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a key player in the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a robust market..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 19.67% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a key player in the healthcare sector specializing in medical devices, presents a promising opportunity for investors with a potential upside of 19.67%. As..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating the 10.25% Potential Upside in a Challenging Market

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is drawing investor attention with its innovative approach to treating rare diseases. With a current market capitalization of..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 105% Potential Upside in Biotech Innovation

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing the attention of investors with its promise of substantial growth in the biotechnology sector. With a market capitalization of $7.65 billion, this clinical-stage vaccine..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 12.56% Upside Potential for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically within the medical devices industry, offers individual investors a compelling opportunity with a potential 12.56% upside. With..

Revvity, Inc. (RVTY) Stock Report: Analyzing Potential Upside and Analyst Consensus

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the dynamic diagnostics and research industry. With a market capitalization of $11.29 billion, the company has garnered attention..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: Riding the Healthcare Wave with a Promising 10.40% Upside

BrightSpring Health Services, Inc. (BTSG) represents a compelling opportunity for investors focusing on the dynamic healthcare sector. With a market capitalization of $10.63 billion, this Louisville, Kentucky-based company has carved..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 38.92% Potential Upside for Investors

Tempus AI, Inc. (NASDAQ: TEM) is carving out a niche within the healthcare sector through its innovative healthcare technology solutions. With a market capitalization of $8.95 billion, the company is..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 51% Upside Potential in the Biotech Space

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the biotechnology sector with an impressive market capitalization of $13.2 billion. Positioned within the healthcare industry, this biopharmaceutical company is making significant..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 36% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology space, is capturing the attention of investors with its innovative approach to diagnostics and research. The company, headquartered in..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Understanding the 24% Potential Upside in CNS Treatments

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has garnered significant attention within the biopharmaceutical sector, particularly for its innovative approach to addressing central nervous system (CNS) disorders. With a current market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Unveiling a 40% Upside Potential in the Diagnostics Sector

Investors looking into the healthcare sector may find Qiagen N.V. (NYSE: QGEN) an intriguing option, especially given its significant upside potential and robust position within the diagnostics and research industry...

Merck & Co. (MRK) Stock Analysis: Promising Upside with Strong Buy Ratings

Investors keeping a close watch on Merck & Co., Inc. (NYSE: MRK) have reason to be optimistic. This healthcare giant, with a robust market capitalization of $275.09 billion, is a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds